Lung (includes NSCLC, SCLC, Mesothelioma)
Featured Articles
(AACR) Dec 15, 2017 - The novel ERK1/2 kinase inhibitor ulixertinib displayed an acceptable safety profile and had clinical activity in patients whose tumors had mutations in the MAPK cell-signaling pathway, according to data from a phase I clinical trial published in Cancer Discovery, a journal of the American Association for Cancer...
Read Article
(WebMD/HealthDay News) Dec 15, 2017 - A new drug that targets a genetic flaw common to most cancer cells is showing potency against many tumor types.
Read Article
Latest Articles
December 15, 2017
December 15, 2017
December 14, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 13, 2017
December 12, 2017
View More
News Commentary
Editor Image
06 Mar, 2017 | by H. Jack West, MD
I'm dubious about a 62% specificity. The test doesn't conclusively rule out...
View Comment
Editor Image
24 Mar, 2017 | by H. Jack West, MD
It's striking that we've needed yet another revision of the NCCN guidelines in...
View Comment
View More
OBR Green
There are no Lung (includes NSCLC, SCLC, Mesothelioma) OBR Green articles.
OBR Blog
There are no Lung (includes NSCLC, SCLC, Mesothelioma) blog entries.